<DOC>
	<DOCNO>NCT01831648</DOCNO>
	<brief_summary>Various assay use IGF-I measurement French laboratory . Unfortunately , assay give different result sample . As IGF-I also vary age , necessary establish broad population reference value IGF1 concentration IGF1 assay use clinical practice , take account individual variation factor age , nutritional status possible treatment . The objective study establish normative data base large random selection general population , include representation age group ( around 100 subject decade age range ) . This perform available assay kit . Subjects medical condition medication may affect outcome exclude . Normative data include range ( 2.5 97.5 percentile ) mass unit result report mass unit also SD score order able , give patient , compare IGF-I concentration along time , even use different assay .</brief_summary>
	<brief_title>Establishment Reference Values Insulin-like Growth Factor 1 ( IGF1 ) General Population</brief_title>
	<detailed_description>Healthy subject recruit 30 center around France . A total 1000 healthy subject necessary . Each subject clinical examination measurement height weight . Personal medical history record gonadal status evaluate . Biological standard workup perform 80 ml blood sample serum aliquoted , frozen store -80°C . IGF-I level measure assay method available ( serum keep bank use future new method available ) For assay method age group ( Four 3-years group 18 30 year six decade age group 30 89 year ) IGF-I measure . Results express mean , median , standard deviation , 2.5th 97.5th percentile , mass unit . Modelisation accord age factor perform order allow report IGF-I result give individual expression IGF-I Z-score .</detailed_description>
	<criteria>Male female 18 89 year old ( 18 year ≤ age ≤ 89 year ) Consent give patient No history : thyroid disease , liver disease kidney disease metabolic endocrine disease cardiovascular pulmonary disease , neoplastic disease , gastroenterological disease ( malabsorption , parasite , chronic diarrhea , peptic disease ) , psychiatric illness , epilepsy . No medication interfere concentration IGF1 : steroid , antiandrogens , distal diuretic , antiestrogens , enzyme inducer ( rifampin , rifabutin , phenobarbital , phenytoin , carbamazepine , herbal St. John 's wort , efavirenz , nevirapine , griseofulvin , OP'DDD , mitotane ) . No intercurrent illness week precede inclusion No known chronic infectious disease ( BVH , CVH , HIV ) No active smoking Weight/height2 ( BMI ) less 28 kg/m2 great 19 kg/m2 Normal clinical examination Normal blood pressure : child 65 year ( 100 mm Hg &lt; SBP &lt; 140 mmHg , 50 mmHg &lt; PAD &lt; 90 mmHg ) 65 year ( 100 mm Hg &lt; SBP &lt; 150 mmHg , 50 mmHg &lt; SBP &lt; 90mmHg ) Uncontrolled intercurrent illness Pregnant lactate woman Excess alcohol consumption : 50 g/24h chronic acute unable restraint consume alcohol Susceptible use drug Donated blood 3 month precede study Blood transfusion 3 month precede test Exclusion period previous experimental trial . Fasting extended several day . Patient affiliate social security system ( beneficiary )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>89 Years</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>IGF1</keyword>
	<keyword>standard</keyword>
	<keyword>Assays</keyword>
	<keyword>Z-score</keyword>
	<keyword>Healthy volunteer</keyword>
	<keyword>Population</keyword>
</DOC>